GLP-1 RAs (Drug)

F.D.A. Approves Ozempic to Deal with Kidney Illness

The Meals and Drug Management on Tuesday authorized Ozempic to scale back the chance of great headaches in individuals who have each Kind 2 diabetes and protracted kidney illness.Kind 2 diabetes is

January 29, 2025

OpenAI

Novo Nordisk Annual Gross sales Leap on Call for for Ozempic and Wegovy

Novo Nordisk, the Danish pharmaceutical corporate in the back of Ozempic and Wegovy, capped off a moderately turbulent 2024, reporting benefit and earnings on Wednesday that very easily beat Wall Boulevard expectancies.

February 6, 2025

Business

F.D.A. Approves Weight-Loss Drug to Deal with Sleep Apnea

The Meals and Drug Management on Friday licensed the burden loss drug Zepbound to regard obstructive sleep apnea. It’s the first prescription medicine licensed to regard the typical sleep problem.The drug’s maker,

December 21, 2024

Business

New Amgen Drug MariTide Presentations Promising Weight Loss in Early Knowledge

The pharmaceutical producer Amgen introduced on Tuesday that an experimental weight problems drug helped sufferers lose a median of as much as 20 % in their weight in a yr. The drug,

November 26, 2024

Business

GLP-1 RAs (Drug)

F.D.A. Approves Ozempic to Deal with Kidney Illness

Novo Nordisk Annual Gross sales Leap on Call for for Ozempic and Wegovy

F.D.A. Approves Weight-Loss Drug to Deal with Sleep Apnea

New Amgen Drug MariTide Presentations Promising Weight Loss in Early Knowledge

Recent Posts

Categories

Suggestions

GLP-1 RAs (Drug)

F.D.A. Approves Ozempic to Deal with Kidney Illness

Novo Nordisk Annual Gross sales Leap on Call for for Ozempic and Wegovy

F.D.A. Approves Weight-Loss Drug to Deal with Sleep Apnea

New Amgen Drug MariTide Presentations Promising Weight Loss in Early Knowledge

Recent Posts

Categories